glp 1 anesthesia guidelines 2025 American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors Trajectory of weight regain after

Pregnancy outcomes following maternal GLP-1 receptor agonist exposure: A systematic review and meta-analysis

Physiol Mol Biol Plants 29(5):663678

Effect According to Diabetes, Obesity and Metabolism Journal, Tirzepatide provides better value for money than semaglutide for weight reduction. The dual mechanism may offer broader metabolic benefits than Semaglutide, but long-term effects and comprehensive safety profiles are still being studied

Clinical Benefits Directly promotes healing of gastric and duodenal ulcers, reduces inflammatory bowel symptoms, protects against digestive tract damage, and enhances overall mucosal integrity

doi:10.1097/00001648-200203000-00013 Hakimi O, Cameron LC